---
title: 'Prognostic biomarkers for the response to the radiosensitizer nimorazole combined
  with RCTx: a pre-clinical trial in HNSCC xenografts'
date: '2023-08-26'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/37633930/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20230827181309&v=2.17.9.post6+86293ac
source: heidelberg[Affiliation]
description: 'CONCLUSIONS: Nimorazole combined with RCTx improved local tumor control
  in some but not in all HNSCC xenografts. We identified prognostic biomarkers with
  the potential for translation to patients with ...'
disable_comments: true
---
CONCLUSIONS: Nimorazole combined with RCTx improved local tumor control in some but not in all HNSCC xenografts. We identified prognostic biomarkers with the potential for translation to patients with ...